" class="no-js "lang="en-US"> Josh Russell - Medtech Alert
Saturday, June 10, 2023

Breaking News

Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas Quell Therapeutics Signs Agreement with AstraZeneca to Develop and Commercialize Engineered Treg Cell Therapies for Autoimmune Diseases Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430 FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia Sir Richard Roberts Elected to National Academy of Sciences Rocket Pharmaceuticals Receives FDA Fast Track and Orphan Drug Designations for RP-A601 Gene Therapy for PKP2 Arrhythmogenic Cardiomyopathy (ACM) Azafaros Announces Enrollment of First Patient in Phase 2 RAINBOW Study Evaluating AZ-3102 in GM2 and NP-C Patients Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Joshua Russell | MTA

Josh Russell

About Josh Russell

Solutions driven professional passionate about developing innovative and timely technologies that address pressing challenges within the biopharma and pharmaceutical industries.

Related Story

Medtech TV

 Josh Russell, AST, on Small Patch Applications for Drug Products | MTA

Josh Russell, AST, on Small Patch Applications for Drug Products

February 15 2023

In this interview, Josh Russell from AST discusses the range of products offered by the […]

Related People

Josh Russell

Josh Russell

Related Company

AST